Malin L Hultcrantz

54PUBLICATIONS
209CO-AUTHORS
Medical mycologyGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Jul 14, 2026
Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up.

|Jun 12, 2026
Genomic features do not account for differences in multiple myeloma risk by ancestry.

|May 01, 2026
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients.

|Apr 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

|Apr 11, 2026
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study.

Robert Palmason, Elias Eythorsson, Sæmundur Rögnvaldsson

|Feb 24, 2026
Prognosis and patterns of progression in smoldering multiple myeloma.

Theresia Akhlaghi, Kylee H Maclachlan, Adriana Wiggins

Pageof 9

Frequent Collaborators

33 joint publications

Kylee Maclachlan

30 joint publications

Urvi Shah

26 joint publications

Ola Landgren

24 joint publications

Carlyn Tan